- N/T
Triall TRL
We lack of accurate trading data.
This could be attributed to several reasons, including limited exchange liquidity or delisting. Or might be due unable to provide support for exchanges where this asset is currently tradable.
Market CapÂ
$162,259.54Rank #--FDVÂ
--Rank #--Investors
Twitter Followers
Twitter Performance
140Rank by Twitter #8908- 0
- 100
- 1000
- 4000
About TRL
Triall is a company that provides innovative software and services to clinical researchers and patients involved in clinical trials. Clinical trials are research studies that evaluate the safety and effectiveness of new treatments before they can be approved for use in the market.
What makes Triall unique?
Triall is unique compared to other cryptocurrencies because it is specifically designed for the healthcare and clinical trial industry. It offers a platform-native means of payment for software and services related to clinical trials. This focus on the healthcare sector sets Triall apart from other cryptocurrencies that may have a broader range of applications. Additionally, Triall's token, TRL, is a key building block for its future vision of a self-sustaining digital ecosystem where data resources can be exchanged fairly and securely between patients, clinical trial sponsors, and service providers. This emphasis on creating a secure and equitable exchange of data resources further distinguishes Triall from other cryptocurrencies.